"Medconsult Geo" LLC
"Medconsult-Geo" LLC is the German-Georgian contract research organization (CRO), which operates successfully in Georgia and cooperates closely with many world-famous biopharmaceutical companies as well as manufacturers of medical devices and products. “Medconsult-Geo” LLC provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. We can provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance.
For about 12 years, with the direct participation of our scientists and colleagues, several international all phases of clinical studies have been carried out and some are currently in progress.
Our goal is to build up close and long-term cooperation with pharmaceutical companies and medical product manufacturers worldwide, to offer them in Georgia, very attractive conditions, both financial and time-saving, for conducting high-quality clinical trials and beyond that, to achieve together scientifical victories in medicine.
What makes Georgia and, in particular, our contract research organization "Medconsult-Geo" LLC such an interesting destination for conducting clinical studies?
1. The preparatory phase for the implementation of clinical studies or the collection of all legally prescribed procedures takes an average of 4 to 5 months.
These procedures are:
2. For the "Sponsor" company, the implementation of a clinical study in Georgia is associated with significantly lower financial expenditure (approx. 50% cost reduction) than is to be expected in other highly developed European, Asian or American countries.
3. It is also worth mentioning the very high quality of the clinical studies carried out, which relates to the following:
5. "Medconsult-Geo" LLC is a member of several international marketing companies and medical-biological associations, including:
We would be delighted if our CRO "Medconsult-Geo" LLC would attract your attention to the implementation of joint clinical studies in Georgia, taking into account our heartfelt wish for long-term cooperation.
I'm looking forward to your response, Sincerely
Director of Company,
Contract Research Organization (CRO)
"Medconsult-Geo" LLC
Dr. jur. Gocha Endeladze
Consultant
Professor in General, Visceral, laparoscopy and Robotic Surgery
Consultant
Professor in Oncology
Consultant
Professor of Radiology
Consultant
Professor of Immunology
Consultant
Professor in Otorhinolaryngology, Head and Neck Surgery
Consultant
Professor in General Surgery
Consultant
Professor in Postoperative Care and Emergency Medicine
Consultant
Professor of General and Visceral Surgery
Consultant
Professor in Laboratory Medicine
Consultant
Professor for Microbiology, Virology and Infection Control
Consultant
Professor for Pulmonology
Consultant
Professor in Plastic Surgery
General Director of Contract Research Organization "Medconsult-Geo" LCC
Consultant, Deputy-Director and Coordinator of the main board Contract Research Organization "Medconsult-Geo" LCC
Professor in General Surgery
Deputy Director and Major Consultant
Scientist and major consultant at Marketing and contact person for the Contract Research Organization "Medconsult-Geo" LCC in USA, Germany, Austria
Head of the marketing and the main contact person for the CRO "Medconsult-Geo" LLC in Asia
Main contact person for the Medconsult-Geo LLC in China, Taiwan, Thailand, South Korea, United Arab Emirates and Saudi Arabia
Consultant and Clinical scientist
Consultant at Marketing and contact person for the Contract Research Organization "Medconsult-Geo" LLC in Canada and USA
Main scientific advisor for management and marketing
Main scientific advisor for management and marketing contact person for the Contract Research Organization (CRO) "Medconsult-Geo" LLC in Europe
Consultant
Consultant at Marketing and contact person for the Contract Research Organization "Medconsult-Geo" in Switzerland and France
Scientific advisor for management and marketing
Scientific advisor for marketing and management as well as the main contact person for the CRO "Medconsult-Geo" LLC in Eastern Europe, latin america, australia and new zealand
Cosultant
Consultant at Marketing and contact person for the Contract Research Organization "Medconsult-Geo" in Turkey, Azerbaijan and Iran
Clinical scientist, General Manager
Assoc. Professor in Gynecology and Reproductology
Clinical Scientist and Major Coordinator of the preclinical Trials
Principal Investigator, Associated Professor Department of Cellular Immunology
Clinical Scientist
Doctor of Medicine. Assistant-Professor, Urologist
Clinical Scientist
Assoc. Professor, Cardiologist at First Central University Clinic
Clinical Scientist
Doctor, Cardiologist at First Central University Clinic
Clinical scientist
Professor in Radiology
Clinical Scientist, Consultant
Medical Doctor in Cardio Vascular Surgery
Clinical Scientist
Cardiologist at Cardiovascular Center
Clinical Scientist
Doctor, Cardiologist at First Central University Clinic
Clinical Scientist
Nephrologist, Doctor of Internal Medicine and Dialysis Therapy
Clinical Scientist
MD, Rheumatologist at Science/Practical Centre of Rheumatology
Clinical Scientist
Medicine Doctor of obstetrics and gynecology
Clinical Scientist
Clinical Scientist in Pharmacology
Clinical Scientist
Doctor of Medicine in Neurosurgeon
Clinical Scientist
Medical Doctor in Cardiology
Clinical Scientis
Doctor of Medicine, Endocrinologist,
Clinical Scientist
Doctor of Medicine, Cardiologist and Radiologist
Clinical Scientist, IT Technical Department
Clinical Scientist
Orthopedic Doctor
Clinical Scientis
Doctor Otolaryngologist
Clinical Scientist
Medical Doctor in Cardiology
Clinical Scientist
Medical Doctor in Cardiology
1. PI - Phase III A Study the Venous Thromboembolic Risk 2016-2018
2. SC - Phase III Diabetes Mellitus type 2 (2014-2016 current)
3. SI - Phase III COPD treatment study (2014-2015)
4. SI - Phase III pneumonia treatment study, (2014-2015)
5. Phase of the study III, Cardiological Study, Sub investigator (2014-2015)
6. Phase of the study III, Nephrology, Sub investigator (2014-2015)
7. Phase of the study III COPD and Cardiovascular Diseases;
8. Phase of the study III for type 2 Diabetes and Cardiovascular Diseases
9. Phase of the study III, for type 2 Diabetes and Cardiovascular Diseases,
10. Phase III, 1 study in Cardiovascular Diseases
11. Phase III Ponesimod in adult with relapsing multiple sclerosis
12. Phase of the study II, Indication Rheumatology, /2016 – 2018/
13. Phase of the study III, Indication Nephrology, /2017 – 2018/
14. Phase of the study III, Indication Cardiology, /2014 – 2015/
15. Phase of the study III, Indication Nephrology, /2017 – 2018/
16. Phase of the study III, Global Alliance for TB Drug Development 11/2017-12/2021
17. Phase of the study III, International Science and Technology Center (ISTC) 2016-2018,
18. Phase of the study III, randomized controlled multi-center trial, 01/2020-01/2025
19. Phase IV, New Diagnostics, TB- Disease, 2015-2017,
20. Phase IV, Tuberculosis, National Institute of Allergy and Infectious Diseases, 2015-2017
21. Phase of the study III-IV, in tuberculosis. 2013-2018
22. Phase of the study III Human Diagnostic, IC in TB Hospital, 2015 – 2016,
23. Swiss National Fund, Switzerland Georgia, 2009-2012, Disability Status Assessment project
24. Timeline 2014-2015, Phase of the study III, Indication Cardiology, Role Subinvestigator
25. Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Subinvestigator
26. Timeline 2016-2018, Phase of the study II, Indication Rheumatology, Role Subinvestigator
27. Timeline 2010 – 2013, Phase of the study III, Indication Cardiology, Role Subinvestigator
28. Timeline 2020 -present, Phase of the study II, Indication Rheumatology, Role Subinvestigator
29. Timeline 2019 -present, Phase of the study III, Indication Cardiology, Role Pharmacist
30. Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Pharmacist
31. Timeline 2014 – 2015, Phase of the study III, Indication Cardiology, Role Pharmacist
32. Timeline 2011-12, Phase of the study III, Indication GOUT, Role Subinvestigator
33. Timeline 2012-2014, Phase of the study II, Indication RA, Role Subinvestigator
34. Timeline 2013-2014, Phase of the study II, Indication RA, Role Subinvestigator
35. Timeline 2014-2015, Phase of the study III, Indication RA, Role Subinvestigator
36. Timeline 2016-2018, Phase of the study II, Indication RA, Role Subinvestigator
37. Timeline 2017-2018, Phase of the study II, Indication RA, Role Subinvestigator